Search results for: EFPIA
Filter search results
OHE Welcomes Patrick Holmes to the Board of Trustees
28 March 2022
…and Associations (EFPIA) Healthcare Systems Working Group. Further, as OHE continues to develop a portfolio of research and consulting in the US policy arena Patrick’s experience with the US health…
Rare Disease Day 2022
28 February 2022
…and Norway (all below 30%). OHE has also carried out research into the role of pharmaceutical innovation in the development of orphan medicines. In collaboration with EFPIA, we developed case…
How Does Pharmaceutical Spending Drive Innovation in Europe?
7 February 2022
…pricing or value-based pricing for medicines (OECD, 2008, Gandjour, 2013; EFPIA, 2014; Toumi et al., 2014; Panteli et al. 2016). These cost containment policies have drawn criticism from analysts in…
Phill O’Neill
22 May 2014
…including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market Understanding Initiative, and G10 Competitiveness Indicators for the EU. Phill is a previous chair of the EFPIA Statistics Group. …
HTA in Japan: Failing to Meet International Good Practice?
15 March 2019
…Council Working Group Report on Good Practices in HTA (Online Appendix). Available at https://www.ispor.org/member-groups/councils-roundtables/health-technology-assessment-council/health-technology-assessment-good-practices-recommendation PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations. December…
Around The World in HTAs: Italy – What’s Next?
20 April 2023
…although this process doesn’t take more time in Italy than in other similar markets ( EFPIA, 2022). However, it is not clear if this reform will address the main critical…
OHE Achievements in 2018
27 December 2018
…in the use of real world evidence by payers. We have also released a Consulting Report with funding from EFPIA to address good governance arrangements to improve R&D efficiency. Earlier…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…Innovative Pharmaceutical Industry in the Slovak Republic ( AIFP), a member of EFPIA, the Office of Health Economics (OHE) accepted the challenge of estimating the most appropriate, up-to-date discount rate,…
OHE at ISPOR Europe: Presentations
19 November 2014
…It worth It? Moderator: Adrian Towse (OHE), with.Hans-Georg Eichler (EMA), Richard Bergstrom (EFPIA), Carole Longson (NICE), and Alric Reuther (IQWiG). Adaptive pathways intro_ispor_second_plenary_nov14 from Office of Health Economics Value-based…